Advertisement

Topics

Bill & Melinda Gates Foundation supports development of Novartis’ cryptosporidiosis therapy

09:07 EST 15 Feb 2018 | EPM Magazine

Novartis has formed an alliance with the Bill & Melinda Gates Foundation to further develop its drug candidate, KDU731, for the treatment of cryptosporidiosis — a cause of infectious diarrhoea in children.

Original Article: Bill & Melinda Gates Foundation supports development of Novartis’ cryptosporidiosis therapy

NEXT ARTICLE

More From BioPortfolio on "Bill & Melinda Gates Foundation supports development of Novartis’ cryptosporidiosis therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...